Editas Medicine
EDIT
EDIT
203 hedge funds and large institutions have $64.8M invested in Editas Medicine in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
34% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 58
65% less capital invested
Capital invested by funds: $188M → $64.8M (-$123M)
Holders
203
Holding in Top 10
–
Calls
$396K
Puts
$388K
Top Buyers
1 | +$1.84M | |
2 | +$1.43M | |
3 | +$1.36M | |
4 |
UBS Group
Zurich,
Switzerland
|
+$895K |
5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$881K |
Top Sellers
1 | -$16.7M | |
2 | -$5M | |
3 | -$4.02M | |
4 |
HF
HRT Financial
New York
|
-$1.53M |
5 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$933K |